nodes	percent_of_prediction	percent_of_DWPC	metapath
Didanosine—Zalcitabine—Lamivudine—acquired immunodeficiency syndrome	0.177	1	CrCrCtD
Didanosine—SLC29A2—Zidovudine—acquired immunodeficiency syndrome	0.129	0.718	CbGbCtD
Didanosine—Nucleoside Reverse Transcriptase Inhibitors—Abacavir—acquired immunodeficiency syndrome	0.101	0.184	CiPCiCtD
Didanosine—Nucleoside Reverse Transcriptase Inhibitors—Zidovudine—acquired immunodeficiency syndrome	0.101	0.184	CiPCiCtD
Didanosine—Nucleoside Reverse Transcriptase Inhibitors—Stavudine—acquired immunodeficiency syndrome	0.101	0.184	CiPCiCtD
Didanosine—Nucleoside Reverse Transcriptase Inhibitors—Lamivudine—acquired immunodeficiency syndrome	0.0768	0.139	CiPCiCtD
Didanosine—Nucleoside Analog—Stavudine—acquired immunodeficiency syndrome	0.0456	0.0826	CiPCiCtD
Didanosine—Nucleoside Analog—Zidovudine—acquired immunodeficiency syndrome	0.0456	0.0826	CiPCiCtD
Didanosine—Nucleoside Analog—Abacavir—acquired immunodeficiency syndrome	0.0456	0.0826	CiPCiCtD
Didanosine—Nucleoside Analog—Lamivudine—acquired immunodeficiency syndrome	0.0345	0.0626	CiPCiCtD
Didanosine—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.0298	0.165	CbGbCtD
Didanosine—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0119	0.0659	CbGbCtD
Didanosine—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.00918	0.051	CbGbCtD
Didanosine—PNP—blood plasma—acquired immunodeficiency syndrome	0.00247	0.173	CbGeAlD
Didanosine—PNP—lymphoid tissue—acquired immunodeficiency syndrome	0.000963	0.0673	CbGeAlD
Didanosine—PNP—digestive system—acquired immunodeficiency syndrome	0.000951	0.0665	CbGeAlD
Didanosine—PNP—blood—acquired immunodeficiency syndrome	0.000906	0.0633	CbGeAlD
Didanosine—PNP—bone marrow—acquired immunodeficiency syndrome	0.000877	0.0613	CbGeAlD
Didanosine—PNP—lung—acquired immunodeficiency syndrome	0.000795	0.0555	CbGeAlD
Didanosine—PNP—nervous system—acquired immunodeficiency syndrome	0.000736	0.0514	CbGeAlD
Didanosine—PNP—central nervous system—acquired immunodeficiency syndrome	0.000708	0.0495	CbGeAlD
Didanosine—SLC29A2—blood—acquired immunodeficiency syndrome	0.000681	0.0476	CbGeAlD
Didanosine—SLC29A2—vagina—acquired immunodeficiency syndrome	0.000631	0.0441	CbGeAlD
Didanosine—PNP—brain—acquired immunodeficiency syndrome	0.000562	0.0393	CbGeAlD
Didanosine—SLC29A2—brain—acquired immunodeficiency syndrome	0.000422	0.0295	CbGeAlD
Didanosine—SLC29A2—lymph node—acquired immunodeficiency syndrome	0.000408	0.0285	CbGeAlD
Didanosine—SLC29A1—lymphoid tissue—acquired immunodeficiency syndrome	0.000359	0.0251	CbGeAlD
Didanosine—SLC29A1—digestive system—acquired immunodeficiency syndrome	0.000354	0.0247	CbGeAlD
Didanosine—SLC29A1—blood—acquired immunodeficiency syndrome	0.000337	0.0236	CbGeAlD
Didanosine—SLC29A1—bone marrow—acquired immunodeficiency syndrome	0.000327	0.0228	CbGeAlD
Didanosine—SLC29A1—vagina—acquired immunodeficiency syndrome	0.000313	0.0219	CbGeAlD
Didanosine—SLC29A1—lung—acquired immunodeficiency syndrome	0.000296	0.0207	CbGeAlD
Didanosine—SLC29A1—nervous system—acquired immunodeficiency syndrome	0.000274	0.0191	CbGeAlD
Didanosine—SLC29A1—central nervous system—acquired immunodeficiency syndrome	0.000264	0.0184	CbGeAlD
Didanosine—SLC22A6—brain—acquired immunodeficiency syndrome	0.000262	0.0183	CbGeAlD
Didanosine—SLC29A1—brain—acquired immunodeficiency syndrome	0.000209	0.0146	CbGeAlD
Didanosine—SLC29A1—lymph node—acquired immunodeficiency syndrome	0.000202	0.0141	CbGeAlD
Didanosine—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	4.36e-05	0.000572	CcSEcCtD
Didanosine—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	4.36e-05	0.000571	CcSEcCtD
Didanosine—Flatulence—Delavirdine—acquired immunodeficiency syndrome	4.35e-05	0.000571	CcSEcCtD
Didanosine—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	4.34e-05	0.000569	CcSEcCtD
Didanosine—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	4.31e-05	0.000565	CcSEcCtD
Didanosine—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	4.3e-05	0.000564	CcSEcCtD
Didanosine—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	4.29e-05	0.000562	CcSEcCtD
Didanosine—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	4.29e-05	0.000562	CcSEcCtD
Didanosine—Hypoaesthesia—Lamivudine—acquired immunodeficiency syndrome	4.29e-05	0.000562	CcSEcCtD
Didanosine—Anaemia—Efavirenz—acquired immunodeficiency syndrome	4.27e-05	0.000559	CcSEcCtD
Didanosine—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	4.27e-05	0.000559	CcSEcCtD
Didanosine—Pain—Nelfinavir—acquired immunodeficiency syndrome	4.23e-05	0.000555	CcSEcCtD
Didanosine—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	4.23e-05	0.000554	CcSEcCtD
Didanosine—Pain—Stavudine—acquired immunodeficiency syndrome	4.22e-05	0.000553	CcSEcCtD
Didanosine—Chills—Ritonavir—acquired immunodeficiency syndrome	4.21e-05	0.000552	CcSEcCtD
Didanosine—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	4.2e-05	0.00055	CcSEcCtD
Didanosine—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	4.18e-05	0.000548	CcSEcCtD
Didanosine—Malaise—Efavirenz—acquired immunodeficiency syndrome	4.16e-05	0.000546	CcSEcCtD
Didanosine—Myalgia—Indinavir—acquired immunodeficiency syndrome	4.16e-05	0.000545	CcSEcCtD
Didanosine—Arthralgia—Indinavir—acquired immunodeficiency syndrome	4.16e-05	0.000545	CcSEcCtD
Didanosine—Pain—Abacavir—acquired immunodeficiency syndrome	4.16e-05	0.000545	CcSEcCtD
Didanosine—Discomfort—Indinavir—acquired immunodeficiency syndrome	4.11e-05	0.000539	CcSEcCtD
Didanosine—Anorexia—Zidovudine—acquired immunodeficiency syndrome	4.09e-05	0.000536	CcSEcCtD
Didanosine—Anaemia—Delavirdine—acquired immunodeficiency syndrome	4.08e-05	0.000535	CcSEcCtD
Didanosine—Dry mouth—Indinavir—acquired immunodeficiency syndrome	4.07e-05	0.000533	CcSEcCtD
Didanosine—Chills—Saquinavir—acquired immunodeficiency syndrome	4.05e-05	0.000531	CcSEcCtD
Didanosine—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	4.05e-05	0.000531	CcSEcCtD
Didanosine—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	4.04e-05	0.00053	CcSEcCtD
Didanosine—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	4.04e-05	0.00053	CcSEcCtD
Didanosine—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	4.03e-05	0.000529	CcSEcCtD
Didanosine—Flatulence—Ritonavir—acquired immunodeficiency syndrome	4.03e-05	0.000528	CcSEcCtD
Didanosine—Alopecia—Saquinavir—acquired immunodeficiency syndrome	3.99e-05	0.000523	CcSEcCtD
Didanosine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	3.99e-05	0.000523	CcSEcCtD
Didanosine—Malaise—Delavirdine—acquired immunodeficiency syndrome	3.98e-05	0.000522	CcSEcCtD
Didanosine—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	3.97e-05	0.000521	CcSEcCtD
Didanosine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	3.96e-05	0.00052	CcSEcCtD
Didanosine—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	3.95e-05	0.000518	CcSEcCtD
Didanosine—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	3.93e-05	0.000515	CcSEcCtD
Didanosine—Myalgia—Efavirenz—acquired immunodeficiency syndrome	3.93e-05	0.000515	CcSEcCtD
Didanosine—Rash—Amprenavir—acquired immunodeficiency syndrome	3.93e-05	0.000515	CcSEcCtD
Didanosine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	3.93e-05	0.000515	CcSEcCtD
Didanosine—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	3.91e-05	0.000513	CcSEcCtD
Didanosine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	3.91e-05	0.000513	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	3.91e-05	0.000512	CcSEcCtD
Didanosine—Headache—Amprenavir—acquired immunodeficiency syndrome	3.91e-05	0.000512	CcSEcCtD
Didanosine—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	3.9e-05	0.000512	CcSEcCtD
Didanosine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	3.9e-05	0.000511	CcSEcCtD
Didanosine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	3.9e-05	0.000511	CcSEcCtD
Didanosine—Discomfort—Efavirenz—acquired immunodeficiency syndrome	3.88e-05	0.000509	CcSEcCtD
Didanosine—Flatulence—Saquinavir—acquired immunodeficiency syndrome	3.87e-05	0.000508	CcSEcCtD
Didanosine—Chills—Lamivudine—acquired immunodeficiency syndrome	3.87e-05	0.000507	CcSEcCtD
Didanosine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	3.85e-05	0.000505	CcSEcCtD
Didanosine—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	3.84e-05	0.000504	CcSEcCtD
Didanosine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	3.84e-05	0.000504	CcSEcCtD
Didanosine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	3.84e-05	0.000504	CcSEcCtD
Didanosine—Alopecia—Lamivudine—acquired immunodeficiency syndrome	3.81e-05	0.000499	CcSEcCtD
Didanosine—Anorexia—Indinavir—acquired immunodeficiency syndrome	3.8e-05	0.000498	CcSEcCtD
Didanosine—Anaemia—Ritonavir—acquired immunodeficiency syndrome	3.78e-05	0.000495	CcSEcCtD
Didanosine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	3.77e-05	0.000495	CcSEcCtD
Didanosine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	3.76e-05	0.000494	CcSEcCtD
Didanosine—Myalgia—Delavirdine—acquired immunodeficiency syndrome	3.76e-05	0.000493	CcSEcCtD
Didanosine—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	3.76e-05	0.000493	CcSEcCtD
Didanosine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	3.73e-05	0.000489	CcSEcCtD
Didanosine—Discomfort—Delavirdine—acquired immunodeficiency syndrome	3.72e-05	0.000487	CcSEcCtD
Didanosine—Nausea—Amprenavir—acquired immunodeficiency syndrome	3.7e-05	0.000485	CcSEcCtD
Didanosine—Flatulence—Lamivudine—acquired immunodeficiency syndrome	3.7e-05	0.000485	CcSEcCtD
Didanosine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	3.69e-05	0.000484	CcSEcCtD
Didanosine—Malaise—Ritonavir—acquired immunodeficiency syndrome	3.68e-05	0.000483	CcSEcCtD
Didanosine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	3.68e-05	0.000482	CcSEcCtD
Didanosine—Pain—Zidovudine—acquired immunodeficiency syndrome	3.67e-05	0.000481	CcSEcCtD
Didanosine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	3.67e-05	0.000481	CcSEcCtD
Didanosine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	3.66e-05	0.000479	CcSEcCtD
Didanosine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	3.65e-05	0.000478	CcSEcCtD
Didanosine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	3.63e-05	0.000477	CcSEcCtD
Didanosine—Anaemia—Saquinavir—acquired immunodeficiency syndrome	3.63e-05	0.000476	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	3.63e-05	0.000476	CcSEcCtD
Didanosine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	3.62e-05	0.000474	CcSEcCtD
Didanosine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	3.59e-05	0.000471	CcSEcCtD
Didanosine—Infection—Delavirdine—acquired immunodeficiency syndrome	3.58e-05	0.00047	CcSEcCtD
Didanosine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	3.58e-05	0.000469	CcSEcCtD
Didanosine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	3.58e-05	0.000469	CcSEcCtD
Didanosine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	3.55e-05	0.000465	CcSEcCtD
Didanosine—Malaise—Saquinavir—acquired immunodeficiency syndrome	3.55e-05	0.000465	CcSEcCtD
Didanosine—Asthenia—Stavudine—acquired immunodeficiency syndrome	3.54e-05	0.000464	CcSEcCtD
Didanosine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	3.53e-05	0.000463	CcSEcCtD
Didanosine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	3.52e-05	0.000461	CcSEcCtD
Didanosine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	3.51e-05	0.00046	CcSEcCtD
Didanosine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	3.51e-05	0.00046	CcSEcCtD
Didanosine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	3.5e-05	0.000459	CcSEcCtD
Didanosine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	3.5e-05	0.000458	CcSEcCtD
Didanosine—Pruritus—Stavudine—acquired immunodeficiency syndrome	3.49e-05	0.000458	CcSEcCtD
Didanosine—Asthenia—Abacavir—acquired immunodeficiency syndrome	3.49e-05	0.000457	CcSEcCtD
Didanosine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	3.48e-05	0.000456	CcSEcCtD
Didanosine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	3.48e-05	0.000456	CcSEcCtD
Didanosine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	3.47e-05	0.000454	CcSEcCtD
Didanosine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	3.47e-05	0.000454	CcSEcCtD
Didanosine—Pruritus—Abacavir—acquired immunodeficiency syndrome	3.44e-05	0.000451	CcSEcCtD
Didanosine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	3.44e-05	0.000451	CcSEcCtD
Didanosine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	3.44e-05	0.00045	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	3.43e-05	0.00045	CcSEcCtD
Didanosine—Pain—Indinavir—acquired immunodeficiency syndrome	3.41e-05	0.000447	CcSEcCtD
Didanosine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	3.4e-05	0.000446	CcSEcCtD
Didanosine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	3.39e-05	0.000444	CcSEcCtD
Didanosine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	3.39e-05	0.000444	CcSEcCtD
Didanosine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	3.39e-05	0.000444	CcSEcCtD
Didanosine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	3.38e-05	0.000444	CcSEcCtD
Didanosine—Malaise—Lamivudine—acquired immunodeficiency syndrome	3.38e-05	0.000443	CcSEcCtD
Didanosine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	3.38e-05	0.000443	CcSEcCtD
Didanosine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	3.36e-05	0.00044	CcSEcCtD
Didanosine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	3.35e-05	0.000439	CcSEcCtD
Didanosine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	3.35e-05	0.000439	CcSEcCtD
Didanosine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	3.33e-05	0.000436	CcSEcCtD
Didanosine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	3.32e-05	0.000435	CcSEcCtD
Didanosine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	3.31e-05	0.000434	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	3.28e-05	0.000431	CcSEcCtD
Didanosine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	3.28e-05	0.000429	CcSEcCtD
Didanosine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	3.27e-05	0.000429	CcSEcCtD
Didanosine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	3.26e-05	0.000428	CcSEcCtD
Didanosine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	3.26e-05	0.000428	CcSEcCtD
Didanosine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	3.25e-05	0.000426	CcSEcCtD
Didanosine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	3.24e-05	0.000424	CcSEcCtD
Didanosine—Pain—Efavirenz—acquired immunodeficiency syndrome	3.22e-05	0.000422	CcSEcCtD
Didanosine—Rash—Nevirapine—acquired immunodeficiency syndrome	3.22e-05	0.000422	CcSEcCtD
Didanosine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	3.22e-05	0.000422	CcSEcCtD
Didanosine—Headache—Nevirapine—acquired immunodeficiency syndrome	3.2e-05	0.00042	CcSEcCtD
Didanosine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	3.19e-05	0.000419	CcSEcCtD
Didanosine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	3.19e-05	0.000419	CcSEcCtD
Didanosine—Infection—Saquinavir—acquired immunodeficiency syndrome	3.19e-05	0.000418	CcSEcCtD
Didanosine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	3.18e-05	0.000417	CcSEcCtD
Didanosine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	3.17e-05	0.000416	CcSEcCtD
Didanosine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	3.16e-05	0.000414	CcSEcCtD
Didanosine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	3.15e-05	0.000413	CcSEcCtD
Didanosine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	3.15e-05	0.000413	CcSEcCtD
Didanosine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	3.15e-05	0.000413	CcSEcCtD
Didanosine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	3.14e-05	0.000412	CcSEcCtD
Didanosine—Vomiting—Stavudine—acquired immunodeficiency syndrome	3.14e-05	0.000411	CcSEcCtD
Didanosine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	3.13e-05	0.000411	CcSEcCtD
Didanosine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	3.12e-05	0.000409	CcSEcCtD
Didanosine—Rash—Nelfinavir—acquired immunodeficiency syndrome	3.12e-05	0.000409	CcSEcCtD
Didanosine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	3.12e-05	0.000409	CcSEcCtD
Didanosine—Rash—Stavudine—acquired immunodeficiency syndrome	3.11e-05	0.000408	CcSEcCtD
Didanosine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	3.11e-05	0.000407	CcSEcCtD
Didanosine—Headache—Nelfinavir—acquired immunodeficiency syndrome	3.1e-05	0.000406	CcSEcCtD
Didanosine—Headache—Stavudine—acquired immunodeficiency syndrome	3.09e-05	0.000405	CcSEcCtD
Didanosine—Vomiting—Abacavir—acquired immunodeficiency syndrome	3.09e-05	0.000405	CcSEcCtD
Didanosine—Pain—Delavirdine—acquired immunodeficiency syndrome	3.08e-05	0.000404	CcSEcCtD
Didanosine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	3.08e-05	0.000404	CcSEcCtD
Didanosine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	3.08e-05	0.000403	CcSEcCtD
Didanosine—Rash—Abacavir—acquired immunodeficiency syndrome	3.06e-05	0.000402	CcSEcCtD
Didanosine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	3.06e-05	0.000401	CcSEcCtD
Didanosine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	3.06e-05	0.000401	CcSEcCtD
Didanosine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	3.06e-05	0.000401	CcSEcCtD
Didanosine—Headache—Abacavir—acquired immunodeficiency syndrome	3.04e-05	0.000399	CcSEcCtD
Didanosine—Infection—Lamivudine—acquired immunodeficiency syndrome	3.04e-05	0.000399	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	3.04e-05	0.000398	CcSEcCtD
Didanosine—Nausea—Nevirapine—acquired immunodeficiency syndrome	3.04e-05	0.000398	CcSEcCtD
Didanosine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	3.03e-05	0.000398	CcSEcCtD
Didanosine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	3e-05	0.000393	CcSEcCtD
Didanosine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	2.99e-05	0.000392	CcSEcCtD
Didanosine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	2.98e-05	0.00039	CcSEcCtD
Didanosine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	2.98e-05	0.00039	CcSEcCtD
Didanosine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	2.95e-05	0.000386	CcSEcCtD
Didanosine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	2.94e-05	0.000385	CcSEcCtD
Didanosine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	2.94e-05	0.000385	CcSEcCtD
Didanosine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	2.93e-05	0.000385	CcSEcCtD
Didanosine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	2.93e-05	0.000385	CcSEcCtD
Didanosine—Nausea—Stavudine—acquired immunodeficiency syndrome	2.93e-05	0.000384	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	2.92e-05	0.000383	CcSEcCtD
Didanosine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	2.92e-05	0.000383	CcSEcCtD
Didanosine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	2.9e-05	0.00038	CcSEcCtD
Didanosine—Nausea—Abacavir—acquired immunodeficiency syndrome	2.89e-05	0.000378	CcSEcCtD
Didanosine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	2.88e-05	0.000378	CcSEcCtD
Didanosine—Asthenia—Indinavir—acquired immunodeficiency syndrome	2.86e-05	0.000375	CcSEcCtD
Didanosine—Pain—Ritonavir—acquired immunodeficiency syndrome	2.85e-05	0.000374	CcSEcCtD
Didanosine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	2.85e-05	0.000374	CcSEcCtD
Didanosine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	2.85e-05	0.000374	CcSEcCtD
Didanosine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	2.82e-05	0.00037	CcSEcCtD
Didanosine—Pruritus—Indinavir—acquired immunodeficiency syndrome	2.82e-05	0.00037	CcSEcCtD
Didanosine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	2.79e-05	0.000366	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	2.79e-05	0.000366	CcSEcCtD
Didanosine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	2.78e-05	0.000364	CcSEcCtD
Didanosine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	2.75e-05	0.00036	CcSEcCtD
Didanosine—Pain—Saquinavir—acquired immunodeficiency syndrome	2.74e-05	0.00036	CcSEcCtD
Didanosine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	2.73e-05	0.000358	CcSEcCtD
Didanosine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	2.73e-05	0.000357	CcSEcCtD
Didanosine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	2.73e-05	0.000357	CcSEcCtD
Didanosine—Rash—Zidovudine—acquired immunodeficiency syndrome	2.7e-05	0.000354	CcSEcCtD
Didanosine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	2.7e-05	0.000354	CcSEcCtD
Didanosine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	2.7e-05	0.000354	CcSEcCtD
Didanosine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	2.69e-05	0.000353	CcSEcCtD
Didanosine—Headache—Zidovudine—acquired immunodeficiency syndrome	2.69e-05	0.000352	CcSEcCtD
Didanosine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	2.67e-05	0.000349	CcSEcCtD
Didanosine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	2.66e-05	0.000349	CcSEcCtD
Didanosine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	2.66e-05	0.000348	CcSEcCtD
Didanosine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	2.64e-05	0.000346	CcSEcCtD
Didanosine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	2.64e-05	0.000346	CcSEcCtD
Didanosine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	2.62e-05	0.000344	CcSEcCtD
Didanosine—Pain—Lamivudine—acquired immunodeficiency syndrome	2.62e-05	0.000343	CcSEcCtD
Didanosine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	2.59e-05	0.000339	CcSEcCtD
Didanosine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	2.58e-05	0.000338	CcSEcCtD
Didanosine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	2.55e-05	0.000334	CcSEcCtD
Didanosine—Nausea—Zidovudine—acquired immunodeficiency syndrome	2.55e-05	0.000334	CcSEcCtD
Didanosine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	2.54e-05	0.000333	CcSEcCtD
Didanosine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	2.54e-05	0.000333	CcSEcCtD
Didanosine—Vomiting—Indinavir—acquired immunodeficiency syndrome	2.54e-05	0.000332	CcSEcCtD
Didanosine—Rash—Indinavir—acquired immunodeficiency syndrome	2.51e-05	0.00033	CcSEcCtD
Didanosine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	2.51e-05	0.000329	CcSEcCtD
Didanosine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	2.5e-05	0.000328	CcSEcCtD
Didanosine—Headache—Indinavir—acquired immunodeficiency syndrome	2.5e-05	0.000328	CcSEcCtD
Didanosine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	2.47e-05	0.000323	CcSEcCtD
Didanosine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	2.46e-05	0.000322	CcSEcCtD
Didanosine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	2.42e-05	0.000317	CcSEcCtD
Didanosine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	2.42e-05	0.000317	CcSEcCtD
Didanosine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	2.4e-05	0.000314	CcSEcCtD
Didanosine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	2.39e-05	0.000314	CcSEcCtD
Didanosine—Rash—Efavirenz—acquired immunodeficiency syndrome	2.38e-05	0.000311	CcSEcCtD
Didanosine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	2.37e-05	0.000311	CcSEcCtD
Didanosine—Nausea—Indinavir—acquired immunodeficiency syndrome	2.37e-05	0.000311	CcSEcCtD
Didanosine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	2.36e-05	0.00031	CcSEcCtD
Didanosine—Headache—Efavirenz—acquired immunodeficiency syndrome	2.36e-05	0.000309	CcSEcCtD
Didanosine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	2.36e-05	0.000309	CcSEcCtD
Didanosine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	2.3e-05	0.000302	CcSEcCtD
Didanosine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	2.29e-05	0.000301	CcSEcCtD
Didanosine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	2.28e-05	0.000299	CcSEcCtD
Didanosine—Rash—Delavirdine—acquired immunodeficiency syndrome	2.27e-05	0.000298	CcSEcCtD
Didanosine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	2.27e-05	0.000298	CcSEcCtD
Didanosine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	2.27e-05	0.000298	CcSEcCtD
Didanosine—Headache—Delavirdine—acquired immunodeficiency syndrome	2.26e-05	0.000296	CcSEcCtD
Didanosine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	2.26e-05	0.000296	CcSEcCtD
Didanosine—Nausea—Efavirenz—acquired immunodeficiency syndrome	2.24e-05	0.000293	CcSEcCtD
Didanosine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	2.2e-05	0.000288	CcSEcCtD
Didanosine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	2.2e-05	0.000288	CcSEcCtD
Didanosine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	2.17e-05	0.000284	CcSEcCtD
Didanosine—Nausea—Delavirdine—acquired immunodeficiency syndrome	2.14e-05	0.000281	CcSEcCtD
Didanosine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	2.12e-05	0.000278	CcSEcCtD
Didanosine—Rash—Ritonavir—acquired immunodeficiency syndrome	2.1e-05	0.000276	CcSEcCtD
Didanosine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	2.1e-05	0.000275	CcSEcCtD
Didanosine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	2.09e-05	0.000275	CcSEcCtD
Didanosine—Headache—Ritonavir—acquired immunodeficiency syndrome	2.09e-05	0.000274	CcSEcCtD
Didanosine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	2.04e-05	0.000267	CcSEcCtD
Didanosine—Rash—Saquinavir—acquired immunodeficiency syndrome	2.02e-05	0.000265	CcSEcCtD
Didanosine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	2.02e-05	0.000265	CcSEcCtD
Didanosine—Headache—Saquinavir—acquired immunodeficiency syndrome	2.01e-05	0.000264	CcSEcCtD
Didanosine—Nausea—Ritonavir—acquired immunodeficiency syndrome	1.98e-05	0.00026	CcSEcCtD
Didanosine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	1.95e-05	0.000255	CcSEcCtD
Didanosine—Rash—Lamivudine—acquired immunodeficiency syndrome	1.93e-05	0.000253	CcSEcCtD
Didanosine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	1.93e-05	0.000253	CcSEcCtD
Didanosine—Headache—Lamivudine—acquired immunodeficiency syndrome	1.92e-05	0.000251	CcSEcCtD
Didanosine—Nausea—Saquinavir—acquired immunodeficiency syndrome	1.91e-05	0.00025	CcSEcCtD
Didanosine—Nausea—Lamivudine—acquired immunodeficiency syndrome	1.82e-05	0.000238	CcSEcCtD
